Searched for
BHARAT SERUMS AND VACCINES
CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines dealThe Competition Commission of India has approved Mankind Pharma's Rs 13,630 crore acquisition of Bharat Serums and Vaccines. This acquisiti...
Mankind Pharma is frontrunner in Bharat Serums bidMankind Pharma is in talks to acquire Bharat Serums & Vaccines Ltd., a biopharmaceutical company with brands like Manforce Condoms and Preg...
SII doing best to ramp up COVID-19 vaccine production, says CEO Adar PoonawallaBoth SII and Bharat Biotech are at the forefront of supplying COVID-19 vaccines in the country even as the second wave of the pandemic cont...
Bharat Bio slashes Covid-19 prices by a third to statesSerum Institute of India (SII) had on Wednesday slashed the price of its COVID-19 vaccine 'Covishield' to Rs 300 per dose from the earlier ...
India to send Covaxin, Covishield to other nations as goodwill gestureIndia has decided to export 8.1 lakh doses of Covaxin to Oman, Mongolia, Myanmar, Bahrain, Mauritius, the Philippines and the Maldives as a...
Centre to buy 70 million Covid-19 vaccine doses for its first vaccination phaseThe government has already placed an order for 11 million doses from Serum Institute. In addition, 550,000 doses have been ordered from Bha...
Bharat Biotech set to dispatch first consignment of Covaxin"Today in the evening the first consignment is going out of Hyderabad.... (it is from ) Bharat Biotech. It is going to 11 destinations," an...
Approval to vaccines 'turning point' in India's fight against COVID-19: Niti Aayog"Today is a turning point in India's fight against Covid-19 as two Made-in-India vaccines get approval for emergency use," the Niti Aayog s...
India approves 2 Covid vaccines for emergency useEleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sund...
DCGI approves SII's Covishield and Bharat Biotech's Covaxin for restrictive use in emergency situationThe subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator's approval.
No approval for Covaxin, expert panel seeks more data from Bharat BiotechEarlier on Friday, the expert committee, which is tasked with vetting covid-19 vaccine proposals, recommended emergency licensure for the S...
CDSCO expert panel seeks more data on COVID-19 vaccines from Serum Institute, Bharat BiotechWhile considering Serum Institute's application, the subject expert committee (SEC) of the CDSCO is learnt to have asked for updated safety...
Mumbai company working on horse antibodies Covid treatmentThe equine antisera pathway with which the Mumbai-based company is working is already used in treatments against snake bites, rabies and di...
Advent to buy majority stake in Bharat SerumsUS-based private equity fund Advent International has signed a definitive agreement to acquire a majority stake in Bharat Serums and Vaccin...
Cadila buys JV partner's 50 pc stake in Zydus BSV PharmaZydus BSV Pharma, founded in 2005, is a joint venture (JV) company of Cadila Healthcare and biotech firm Bharat Serums and Vaccines (BSV).
- Gates Foundation to fund two cos for vaccine research
While both the local firms will work on developing cost rotavirus vaccines, Serum will also be involved in the vaccine for pneumonia.
- Piramal to acquire injectible anesthetic biz of Bharat Serums
Piramal Healthcare on Thursday said that it has signed a definitive agreement with Bharat Serums and Vaccines to acquire the latter's injec...